Abstract

IntroductionNintedanib slows disease progression in patients with idiopathic pulmonary fibrosis (IPF) by reducing the rate of decline in forced vital capacity, with an adverse event profile that is manageable for...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Association between weight loss and decline in FVC in patients with IPF
Laurent Vernhet ... Wibke Stansen
-
Laurent Vernhet, et. al.Laurent Vernhet ... Wibke Stansen
28 Sep 2019
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases.
Francesco Bonella ... Yoshikazu Inoue
Respirology (Carlton, Vic.) | VOL. 27
Francesco Bonella, et. al.Francesco Bonella ... Yoshikazu Inoue
27 Feb 2022
Association between weight loss and decline in FVC in patients with IPF*
S Jouneau ... M Lederlin
-
S Jouneau, et. al.S Jouneau ... M Lederlin
28 Feb 2020
Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials
Inga Tschoepe ... Oliver Distler
The Lancet Rheumatology | VOL. 4
Inga Tschoepe, et. al.Inga Tschoepe ... Oliver Distler
01 Sep 2022
View more papers

More From: BMJ Open Respiratory Research

Paper Title
Journal
Date
Author
Internet-delivered cognitive-behaviour therapy for anxiety related to asthma: study protocol for a randomised controlled trial.
Marianne Bonnert ... Catarina Almqvist
BMJ open respiratory research | VOL. 11
Marianne Bonnert, et. al.Marianne Bonnert ... Catarina Almqvist
27 May 2024
DIGIPREDICT: physiological, behavioural and environmental predictors of asthma attacks—a prospective observational study using digital markers and artificial intelligence—study protocol
Amy Hai Yan Chan ... Jeff Harrison
BMJ Open Respiratory Research | VOL. 11
Amy Hai Yan Chan, et. al.Amy Hai Yan Chan ... Jeff Harrison
22 May 2024
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study
Kieran J Rothnie ... Claus F Vogelmeier
BMJ Open Respiratory Research | VOL. 11
Kieran J Rothnie, et. al.Kieran J Rothnie ... Claus F Vogelmeier
21 May 2024
Prevalence, Medicaid use and mortality risk of low FEV1 in adults aged 20–35 years old in the USA: evidence from a population-based retrospective cohort study
Zihui Wang ... Jinping Zheng
BMJ Open Respiratory Research | VOL. 11
Zihui Wang, et. al.Zihui Wang ... Jinping Zheng
15 May 2024
View more papers